Lilly to Supply up to 600,000 Doses of AbCellera-Discovered Antibody, Bebtelovimab, to the U.S. Gove

Bebtelovimab neutralizes Omicron, including subvariant BA.2, as demonstrated by pseudovirus and/or authentic virus dataVANCOUVER, British Columbia--(BUSINESS WIRE)--$ABCL #AbCellera--AbCellera (Nasdaq: ABCL) today announced Eli Lilly and Company (Lilly) has entered into a purchase agreement with the U.S. government...

Related Keywords

United Kingdom ,Vancouver ,British Columbia ,Canada ,British ,Jessica Yingling ,Neil Berkley ,Eli Lilly ,Vaccine Research Center ,Company Lilly ,Abcellera Biologics Inc ,Drug Administration ,National Institutes For Allergy ,Exchange Commission ,Defense Advanced Research Projects Agency ,Business Development ,Emergency Use Authorization ,National Institutes ,Infectious Diseases ,Pandemic Prevention Platform ,Private Securities Litigation Reform Act ,Financial Condition ,Abcellera Biologics ,Melanie Solomon ,